22 January 2021
: Case report 
A 64-Year-Old Man with Low Back Pain Due to Clostridium perfringens Lumbar Discitis
Unknown etiology
Harshil Bhatt1EF*, Sandeep Singh2EFDOI: 10.12659/AJCR.928014
Am J Case Rep 2021; 22:e928014
Table 2. Antimicrobial susceptibilities of C. perfringens.
| Antibiotic | MIC (μg/ml) | Interpretation |
|---|---|---|
| Amoxicillin/Clavulanate | ≤0.5 | S |
| Ampicillin | ≤0.5 | S |
| Ampicillin/Sulbactam | ≤0.5 | S |
| Cefotetan | ≤4 | S |
| Cefoxitin | ≤1 | S |
| Chloramphenicol | 4 | S |
| Clindamycin | 1 | S |
| Meropenem | ≤0.5 | S |
| Metronidazole | 16 | I |
| Penicillin | ≤0.06 | S |
| Tetracycline | 1 | S |
| Piperacillin/Tazobactam | 0.5 | S |
| S – sensitive; I – intermediate; R – resistant; MIC – minimum inhibitory concentration; Drug susceptibility testing as per Clinical and Laboratory Standards. Institute guidelines (CLSI M11). | ||